SAN DIEGO, April 5, 2018 /PRNewswire/ -- NuVasive, Inc.
(NASDAQ: NUVA), the leader in spine technology innovation, focused
on transforming spine surgery with minimally disruptive,
procedurally-integrated solutions, today announced the Company is a
sponsor of the International Society for the Advancement of
Spine Surgery, 18th Annual Conference (ISASS) being held April
11-13, 2018, in Toronto, at the
Metro Toronto Convention Centre. NuVasive will host a hands-on
workshop featuring the latest advances in Lateral Single-Position
solutions, as well as a number of podium presentations at ISASS
2018.
The NuVasive Industry Lunch Workshop, Leading. Expanding.
Advancing. Insights to Lateral Procedural Solutions, by J.
Alex Thomas, M.D., will take place
on Thursday, April 12 from
12:00-1:30 p.m. in Room 802A /
802B. For more information, visit
http://www.isass.org/education/conferences/isass18-scientific-program/.
"We encourage attendees to participate in the workshop to see
firsthand how surgeons are already incorporating Lateral
Single-Position solutions to help their patients," said
Matt Link, executive vice president,
strategy, technology and corporate development for NuVasive. "This
equates to increased OR efficiency by reducing the number of times
a patient has to be repositioned and expanding the benefits of
lateral surgery to more spinal levels. Since its launch in
October 2017, the Lateral
Single-Position solution is fully integrated into our portfolio,
and we have received extremely positive feedback from early
adopters who are seeing great results as they take XLIF® to the
next level to create a better and more streamlined surgical
experience for both surgeon and patient."
Additionally, NuVasive will present on podium during ISASS 2018,
touching on topics ranging from advanced implant materials such as
Porous PEEK™ to biologics:
- April 11, 11:14 a.m. Efficacy of a Novel
Microstructured Calcium Phosphate-Collagen Bone Graft in a Rabbit
Posterolateral Spine Fusion Model. Speaker: Greg M. Williams, Ph.D.
- April 13, 8:00 a.m.
Comparing the Osseointegration of Seven Spinal Interbody Device
Materials in an Ovine Bone Implantation Model. Speaker:
Greg M. Williams, Ph.D.
- April 13, 9:00 a.m. PEEK, HA
PEEK and Porous PEEK science. Speaker: Prof. Ken
Gall
Conference attendees can visit NuVasive Booth #201 to experience
the latest innovative spine solutions and systems firsthand from
the NuVasive team of experts and also view research posters in the
exhibit hall.
About NuVasive
NuVasive, Inc. (NASDAQ:
NUVA) is the leader in spine technology innovation, focused on
transforming spine surgery and beyond with minimally disruptive,
procedurally-integrated solutions designed to deliver reproducible
and clinically-proven surgical outcomes. The Company's portfolio
includes access instruments, implantable hardware, biologics,
software systems for surgical planning, navigation and imaging
solutions, magnetically adjustable implant systems for spine and
orthopedics, and intraoperative monitoring service offerings. With
over $1 billion in revenues, NuVasive
has an approximate 2,400 person workforce in more than 40 countries
serving surgeons, hospitals and patients. For more information,
please visit www.nuvasive.com.
Forward-Looking Statements
NuVasive cautions
you that statements included in this news release that are not a
description of historical facts are forward-looking statements that
involve risks, uncertainties, assumptions and other factors which,
if they do not materialize or prove correct, could cause NuVasive's
results to differ materially from historical results or those
expressed or implied by such forward-looking statements. The
potential risks and uncertainties which contribute to the uncertain
nature of these statements include, among others, risks associated
with acceptance of the Company's surgical products and procedures
by spine surgeons, development and acceptance of new products or
product enhancements, clinical and statistical verification of the
benefits achieved via the use of NuVasive's products (including the
iGA® platform), the Company's ability to effectually manage
inventory as it continues to release new products, its ability to
recruit and retain management and key personnel, and the other
risks and uncertainties described in NuVasive's news releases and
periodic filings with the Securities and Exchange Commission.
NuVasive's public filings with the Securities and Exchange
Commission are available at www.sec.gov. NuVasive assumes no
obligation to update any forward-looking statement to reflect
events or circumstances arising after the date on which it was
made.
View original content with
multimedia:http://www.prnewswire.com/news-releases/nuvasive-sponsors-isass-2018-hosts-workshops-and-presentations-300625259.html
SOURCE NuVasive, Inc.